BridgeMD
New treatment option for Stroke (CVA) or Transient Ischemic Attack
Official title Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors
ClinicalTrials.gov ID: NCT07266662
What this study is testing
- What it's testing
- This study aims to evaluate the effectiveness of two rehabilitation techniques-Sensory Augmentation (using mirror therapy) and Neuromodulation (using transcranial direct current stimulation, tDCS)-in improving motor recovery among stroke survivors. Stroke often results in long-term impairments, particularly in upper limb motor function, which is critical for daily activities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 56
You may be able to join if
- Age: 45-65
- Gender: both male and female
- Ischemic stroke
- Diagnosed cases of middle cerebral artery stroke by neurologist
- Stage of recovery - Chronic (more than 6 months)
You likely can't join if
- Vestibular Dysfunction
- Serious cognitive impairment,
- Severe vision or visuospatial neglect
- Spasticity (Modified Ashworth scale \>3)
- Upper extremity contractures
- Upper extremity fractures
See the full eligibility criteria
- Age: 45-65
- Gender: both male and female
- Ischemic stroke
- Diagnosed cases of middle cerebral artery stroke by neurologist
- Stage of recovery - Chronic (more than 6 months)
- Burnstromm recovery stage 3
- Good Compliance
- Vestibular Dysfunction
- Serious cognitive impairment,
- Severe vision or visuospatial neglect
- Spasticity (Modified Ashworth scale \>3)
- Upper extremity contractures
- Upper extremity fractures
- Orthopedic disease
- Neurological conditions (other than stroke)
- Recurrence of stroke or epilepsy during the study period
- Serious systemic impairment or concomitant diseases
- Patients refused to participate in the experiment
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 56 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.